Intrinsic Value of S&P & Nasdaq Contact Us

Dynatronics Corporation DYNT OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
23/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Dynatronics Corporation (DYNT) , forward earnings yield 2,000.00%.

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 0.1

Overall SharesGrow Score: 22/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
23/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
75/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
MOAT
20/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — DYNT

Valuation Multiples
P/E (TTM)0.0
Forward P/E0.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.43
Forward EPS (Est.)$0.90
Book Value / Share$0.00
Revenue / Share$3.37
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield2,000.00%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-4.20 $30.41M $-2.27M -7.5%
2017 $-6.81 $35.76M $-4.29M -12%
2018 $-2.64 $64.41M $-3.5M -5.4%
2019 $-1.04 $62.57M $-1.72M -2.7%
2020 $-2.10 $53.41M $-4.32M -8.1%
2021 $0.39 $47.8M $1.21M 2.5%
2022 $-1.32 $44.34M $-4.73M -10.7%
2023 $-1.46 $40.61M $-5.66M -13.9%
2024 $-1.00 $32.53M $-2.7M -8.3%
2025 $-1.43 $27.39M $-10.9M -39.8%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message